SCHEMBL5115538

SCHEMBL5115538

CC(C)C(=O)Nc1cccc(COc2c(Cl)cc(CC(=O)O)cc2Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 11/20 0.56
THRB P10828 11/20 0.56
L3MBTL1 Q9Y468 1/20 0.43
FABP4 P15090 1/20 0.42
FABP5 Q01469 1/20 0.42
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ABL1 P00519 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
RIN1 Q13671 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CAMK2A Q9UQM7 1/20 0.38
CETP P11597 1/20 0.38
AKR1B10 O60218 1/20 0.38
UGT1A9 O60656 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5112714 0.90 THRB (0.55) THRATHRBL3MBTL1
SCHEMBL5107795 0.89 THRA (0.54) THRATHRBL3MBTL1FABP4FABP5
SCHEMBL5119849 0.89 THRA (0.47) THRATHRBL3MBTL1
SCHEMBL5103540 0.89 FABP4 (0.44) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL4933400 0.88 THRA (0.44) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL5117496 0.87 THRA (0.54) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL4934429 0.86 FABP4 (0.45) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL4923133 0.84 FABP4 (0.44) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL5115542 0.83 ALDH1A1 (0.45) THRATHRBL3MBTL1ALDH1A1KMT2A
SCHEMBL4929364 0.83 FABP4 (0.42) THRATHRBFABP4FABP5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885L3MBTL1 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.